Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis
Status:
Unknown status
Trial end date:
2018-09-30
Target enrollment:
Participant gender:
Summary
OBJECTIVE To evaluate the efficacy and safety of the concurrent treatment of 5% Natamycin and
1% Voriconazole in patients affected by fungal keratitis METHODS AND MATERIALS STUDY
POPULATION Patients with smear and or culture proven fungal keratitis presenting to our
Instituts, were eligible for enrollment.
STUDY DESIGN Prospective double masked randomized clinical trial.